OxThera is a clinical stage biotechnology company with its first product in phase III. The company is based in Sweden (Uppsala) and Florida (Gainesville). The company develops products, based on its cell- and enzyme based proprietary technologies,...
Total money raised: $56.8M
OxThera raised $10.3M in unattributed round from IDInvest Partners
OxThera AB Receives SEK 70 Million Financing to Continue its Key Clinical Programs prnewswire.com
OxThera raised $22.1M in unattributed round from HealthCap, Q-Med, Industrifonden, and SLS Venture
OxThera Raises SEK 150 Million in New Round of Financing oxthera.com
OxThera raised $24.4M in unattributed round from HealthCap and SLS Venture
External financing of SEK 165 million secured for Q-Med's oxalate project oxthera.com